Market research on the consumer health industry. Our reports feat...
Market research on the consumer health industry. Our reports feature a wealth of standardised and cross-comparable statistics including total market sizes, market share and share data, distribution and industry trends.
The return of consumers to their busy-pandemic lifestyles had a positive impact on demand for analgesics in Malaysia in 2023. Within this, topical analgesics/anaesthetic remained the largest subcategory, as well as being the key driver of growth.…
In late 2022 and into early 2023, a convergence of COVID-19, seasonal flu, and heightened influenza cases created what the media termed a "tripledemic," impacting Mexico, the US, and Central American nations. While Mexico did not experience the same…
Analgesics in Morocco has continued to develop positively in 2023, with total current value sales set to grow at a faster rate than in 2022 and most categories expected to post improved results in volume terms. Together with population growth and…
Analgesics continued to see solid growth in current value terms in 2023, following the easing of most COVID-19-related restrictions in September 2022. With measures such as lockdowns, mandatory mask-wearing and social distancing no longer in place,…
Analgesics remains the largest category in consumer health in Nigeria. Sales continued to rise in 2023, supported by strong brand positioning and consumer awareness. Other factors driving growth included affordability, widespread availability and a…
Analgesics continues to achieve strong value growth in North Macedonia in 2023 as a result of strong consumer demand for systemic analgesics, especially adult ibuprofen, adult acetaminophen and adult aspirin. Topical analgesics are outperforming…
Per capita consumption of analgesics continued to increase in Norway during 2023 after 2022 saw significant increases in consumption of these products. While there was some stockpiling of analgesics seen in Norway during the early stages of the…
Analgesics is expected to register moderate constant value growth in 2023. In spite of continuing very high inflation, volume growth is also expected to be healthy, and is supported by continuing population growth. Price limits on analgesics is also…
Analgesics benefitted from the era of COVID-19, as consumers sought out pain relief such as acetaminophen and ibuprofen, both of which saw extensive coverage in the media as low-cost products that could treat symptoms of the virus quickly and…
Demand for both adult and paediatric analgesics continued to grow in retail volume terms in 2023. Such products are widely used in Poland, particularly in the case of pain which is fleeting or immediate. With the rapid pace of modern life, consumers…
Analgesics recorded a significant increase in retail volume terms in 2021 and this was followed by even more dynamic growth in 2022. The COVID-19 pandemic and the tough restrictions introduced in 2020 and the beginning of 2021 in order to prevent it…
Despite general economic instability and a rise in prices, the analgesics category in 2023 looks set to achieve a positive performance. However, the current value growth rate is likely to be slower than in the previous year. This can be attributed to…
In 2023, there have been stock shortages for some analgesics in key distribution channels in Saudi Arabia, resulting from producers, suppliers, and/or distributors. As a result, end consumers have been switching to alternative products containing the…
In 2023, analgesics is set to see strong growth supported by rising prices in the context of generally high rates of inflation. After strong growth in 2020 due to stockpiling and decline in 2021, the category returned to growth in 2022 and has…
Due to the high rates of vaccination amongst Singaporeans, systemic analgesics were purchased in high quantities in 2022 to fulfil the demand to self-medicate amidst post-vaccination symptoms and common cold symptoms from later variants of the…
Diclofenac and naproxen are non-steroidal anti-inflammatory analgesics used to relieve mild pain. Both categories saw retail current value sales surge in 2022. Retail current value sales are set to continue to grow over 2023 in both categories,…
Analgesics in Slovenia are projected to experience significant growth in current retail value throughout 2023. Both adult and paediatric analgesics are performing well. During the latter part of the review period, the sector benefited from the…
When it comes to pain management, analgesics is a popular category, specifically acetaminophen. For many consumers, acetaminophen is their go-to preference as it is easily available across various channels. Additionally, it can be bought without…
Despite the overall waning impact of the pandemic in South Korea, simultaneous new outbreaks of COVID-19, influenza, and the common cold (referred to as a “tripledemic” in the country) are leading to a sharp increase in the number of consumers…
Since 2020, a factor supporting the growth of analgesics was the increased tendency of doctors to prescribe acetaminophen, among other common types of analgesics, as a way of managing the symptoms of patients with COVID-19, including muscle and joint…